Chair: I welcome our panelists. We all know how severe this issue is – medicines are unavailable or unaffordable. This is for a variety of reasons, some of it is regulatory – lets not forget that there is a lot of weork done to optimize legislation. There is also often a lack of professional knowledge. …
Slovenia
Special commemorative event at the occasion of the United Nations International Day against Drug Abuse and Illicit Trafficking and Launch of the 2022 World Drug Report
Chair: Welcome. Today, to promote participation, we are conducting this meeting in a hybrid format. I welcome all our panelists, youth ambassadors, and the 26 registered speakers. WDR is historically launched on World Drug Day which is a very important day for us all to advance SDGs and build back better. The theme this year …
Plenary Item 12. Adoption of the report of the Commission on its sixty-fifth session.
Chair: We are having technical difficulties with printing the resolutions, we will therefore change the order of our proceedings, but we will turn to Nigeria who has kindly agreed to act as rapporteur so that we can adopt various parts of the report. We will then move to the resolutions. We only have a few …
Committee of the Whole L5. Promoting comprehensive and scientific evidence-based early prevention
Slovenia: we had constructive informals that redefined the word ‘flexibility’ but we thank all delegates for their constructive approach. We confirmed to delete PP11bis, amend PP11ter and this is agreed in informals. Chair: What is the feeling of the room regarding PP11bis and PP11ter? Are there any comments? I see none. Let’s consider both agreed …
Committee of the Whole L5 Promoting comprehensive and scientific evidence-based early prevention
Chair: We still have a lot of work to do – I hope you’ve had a decent rest and that we can make some progress. Slovenia: Para on gender in OP5 & OP9. Alternative para by Egypt – we are close to consensus. Apparently OP9 is too general. We propose delete end of OP5, keep …
Committee of the Whole Resolution L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs (evening session)
Chair: Can the US introduce to us what are the agreements that you could reach during the informal consultations? USA: thank you Sir. I think we’ve had an extensive discussion on the title, and I think we’re pretty close. We have some new flexibility that we want to offer so I might turn it to …